About 11th Annual European Life Sciences CEO Forum & Exhibition
Back for its 11th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2018 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in the different therapeutic sectors. The Forum also features keynote speeches by KOL, about 60 selected corporate presentations from established (public and private) and emerging biotechs seeking to promote investment and partnering opportunities. There is also a focus on early stage innovation and an elevator session with up 20 presentations by start-ups from BioMed and Digital Health.
On site meetings are facilitated by our online 1-2-1 meeting system, which is available to all participants. We expect up to 350 delegates and 1500+ 1-2-1 meetings to take place on site.
Plenary Sessions will include:
Therapeutic Panels will include:
Confirmed Speakers & Chairs include:
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at 11th Annual European Life Sciences CEO Forum & Exhibition is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact:
Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
Financial, Advisory, Investors in 2018:
AGLAIA BioMedical Ventures B.V.
Apex Healthcare Consulting Ltd.
BAG Health Care GmbH
Bellevue Asset Management AG
Capricorn Venture Partners NV
Edmond de Rothschild Investment Partners Management LTD
Ernst & Young AG
European Investment Bank
European Investment Fund
EVA - the Basel life sciences start-up agency
Gilde Healthcare Partners
goetzpartners (Schweiz) AG
Grabulovski Consulting Services
GrowthCube Partners, LLC
HBM Partners AG
HealthCare Royalty Partners
High-Tech Gruenderfonds Management GmbH
IBB Beteiligungsgesellschaft GmbH
Isis Innovation/University of Oxford (BF)
Jefferies International Limited
Johnson & Johnson Innovation
Merck Ventures B.V.
Nextech Invest Ltd.
Norgine Ventures Management Limited
Novartis Venture Fund
Novo Holdings A/S
OrbiMed Advisors, LLC
Peppermint Venture Partners GmbH
Privateq Advisors AG
Redalpine Venture Partners
Rosetta Capital Ltd.
Silicon Valley Bank
Sofinnova Partners SA
Staatz Business Development & Strategy
Swiss Tech Capital AG
The Fulford Group Ltd.
Torreya Partners (Europe), LLC
TVM Capital China Limited
Ventac Partners GmbH
VI Partners AG